At 11.15 am, October 19, prof. Polosa will host remotely the panel Longer Term Outcomes of Cessation and Harm Reduction with a presentation on "Changes in Health Symptoms - Results and Analysis Methodologies".
According the authors, for every 100 people, 10 to 19 are likely to quit using an e-cigarette; 12 to 16 using varenicline; and 10 to 18 using cytisine. This is compared to the 6 in 100 people likely to quit when using no medicine/e-cigarette or placebo. People using two forms of nicotine replacement therapy at the same time, for example, a combination of nicotine patch and nicotine gum, seemed to have similar rates of quitting to people using e-cigarettes, varenicline and cytisine.
The annual meeting of SRNT, the Society for Research on Nicotine and Tobacco, kicks off on March 15. The conference will host a panel of international experts to discuss the latest news on policy, smoking endgame strategies, scientific research and innovation
Science and gender equality are both vital for the achievement of the internationally agreed development goals, including the 2030 Agenda for Sustainable Development. Over the past decades, the global community…
Webinar Understanding Synthetic Nicotine: A Comprehensive Scientific and Legal Review The webinar will begin with a scientific review of synthetic nicotine, including how it is made, how testing can distinguish…
EXPERIMENTAL BIOLOGY 2022Pennsylvania Convention Center – Philadelphia, Pennsylvania, USAApril 2-5, 2022 Abstract Title: Electronic Nicotine Delivery Systems Exhibit LowerToxicity Compared to Cigarettes: “The Replica Study Experience”Presenting Author: Alfio DistefanoSession Title: Interdisciplinary/translational science (SEBM)Session Day: Sunday,…
In the last two years, the CoEHAR Replica project confirmed the results obtained from the major international studies. It also validated with additional techniques their outcomes under independent conditions.
The new study by CoEHAR, "Nicotine dosimetry and stability in cambridge filter PADs (CFPs) following different smoking regime protocols and storage conditions", provided new guidelines for future multicentric studies in the low-risk products
A new study in Nicotine & Tobacco Research, published by Oxford University Press, finds that the use of high-strength nicotine e-cigarettes can help adults with schizophrenia spectrum disorders quit smoking
Catania February, 2021 – The Director of CoEHAR Giovanni Li Volti presented at the meeting of the Society for Research on Nicotine & Tobacco (SRNT 2021) the study “The Role of cigarette…
We will send you direct emails, without intermediary services, you can withdraw in time by replying directly to the newsletter
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.